Friday, July 03, 2015 3:12:04 PM
Agreed, tough to gain any credibility as a penny stock, but I have a one word, redundant response to that - Engel. It's also why I think they appear to be seeking the European markets, with Engel's support, to rebuild the confidence. But the fact is, as long as Engel will benefit, it is a win-win. Engel is certainly not running a charity and is only involved to win and make money.
I cannot imagine how a negative history of LQMT would positively impact LQMT seeking roads already crossed in the U.S. years ago. It has to be a terrible hindrance - no matter who the CEO is - just the company name would leave a bad taste in someone's mouth.
I saw that Hauck video recently about how there were issues with cost. Although I think that may have been true, or may still be true, it looks like some customers they had approached in the past in the U.S., they approached anew. If they already turned them off, whether it was cost or reputation, it's not easy to gain their trust once again. I think to ignore that fact, is to greatly underestimate how a prior burned customer, or customer that knows of their negative history would not want to do business with them again - on any scale. And with years of soliciting customers and already having doors closed to costs or negative history in the U.S., they won't be able to get that back easily. And then you have that Visser situation, etc. etc. etc. It's why, obviously, it's a 13 cent stock, but you can't really fault the CEO because, blameworthy or not for some of the misdrection (lack of funds is the first obstacle in any business that is hard to overcome and too often causes deals with the devil), he seems pretty resilient and Engel appears to be pretty solid proof of that. Engel is basically the life preserver (and maybe the sole form of life support) for this company at this point. GL.
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM